Intelligent Digital Tools for Screening of Brain Connectivity and Dementia Risk Estimation in People Affected by Mild Cognitive Impairment
NCT05159661 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-04-02
Summary
Every three seconds someone in the world develops dementia. There are over 50 million people worldwide living with dementia and by 2030 this figure is expected to reach 82 million. Besides time-consuming patient investigations with low discriminative power for dementia risk, current treatment options focus on late symptom management. By screening brain connectivity and dementia risk estimation in people affected by mild cognitive impairment, the European Union (EU) funded AI-Mind project will open the door to extending the 'dementia-free' period by offering proper diagnosis and early intervention. AI-Mind will develop two artificial intelligence-based digital tools that will identify dysfunctional brain networks and assess dementia risk. Personalised patient reports will be generated, potentially opening new windows for intervention possibilities.
Conditions
- Cognitive Dysfunction
- Dementia
- Mild Cognitive Impairment
Sponsors & Collaborators
-
Aalto University
collaborator OTHER -
Accelopment AG
collaborator OTHER -
Alzheimer Europe
collaborator OTHER -
BrainSymph AS
collaborator UNKNOWN -
Det Norske Veritas
collaborator UNKNOWN -
Helsinki University Central Hospital
collaborator OTHER -
IRCCS San Raffaele Roma
collaborator OTHER -
Lurtis Rules S.L.
collaborator UNKNOWN -
Neuroconnect Srl
collaborator UNKNOWN -
Oslo Metropolitan University
collaborator OTHER -
Radboud University Medical Center
collaborator OTHER -
Tallinna Ülikool
collaborator UNKNOWN -
Universidad Complutense de Madrid
collaborator OTHER -
Catholic University of the Sacred Heart
collaborator OTHER -
Oslo University Hospital
lead OTHER
Principal Investigators
-
Ira Haraldsen, PhD, MD · Oslo University Hospital
Eligibility
- Min Age
- 60 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2025-09-30
- Completion
- 2026-02-27
Countries
- Finland
- Italy
- Norway
- Spain
Study Locations
More Related Trials
-
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
NCT01078636 ·Status: COMPLETED
-
Multi-modal Neuroimaging in Alzheimer's Disease IMAP+
NCT01638949 ·Status: COMPLETED ·Phase: NA
-
Brain Connectivity Marker for Alzheimer's Disease
NCT06874231 ·Status: RECRUITING
-
Multi-modal Neuroimaging in Alzheimer's Disease
NCT01554202 ·Status: UNKNOWN ·Phase: NA
-
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
NCT06965816 ·Status: COMPLETED
-
Neuro Imaging and Multimodal Alzheimer's Disease
NCT02839187 ·Status: COMPLETED ·Phase: NA
-
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
NCT06561906 ·Status: RECRUITING
-
Positron Emission Tomography of Amyloid in Alzheimer's Disease
NCT00205621 ·Status: SUSPENDED ·Phase: PHASE1
-
Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment
NCT00684281 ·Status: COMPLETED ·Phase: NA
-
Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment
NCT01425957 ·Status: COMPLETED ·Phase: NA
-
National Database of the Virtual Institute of Cerebrovascular Diseases
NCT05925699 ·Status: NOT_YET_RECRUITING
-
The Sunnybrook Dementia Study
NCT01800214 ·Status: ACTIVE_NOT_RECRUITING
-
Assess Fibrin in Brains With AD/ADRD
NCT05336695 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder
NCT07314190 ·Status: ENROLLING_BY_INVITATION
-
Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study
NCT01582919 ·Status: COMPLETED ·Phase: NA
-
Definition, Quantification, and Utility of Biomarkers of Repetitive Brain Injury in Predicting Concussion and Other Long-Term Injury Risks in Patients With Atrial Fibrillation (Concussion AF)
NCT03875131 ·Status: COMPLETED
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
FluoroAv45 Imaging Research-in Alzheimer's Disease
NCT01325259 ·Status: COMPLETED ·Phase: PHASE2
-
SPECT/CT in the Diagnosis of Dementia
NCT01112501 ·Status: COMPLETED
-
Amyloid-β Clearance Mechanisms in Alzheimer's Disease
NCT05059158 ·Status: RECRUITING
-
Multimodal Ocular Imaging in Neurodegeneration
NCT03699644 ·Status: COMPLETED
-
Amyloid PET in Patients With Mild Cognitive Impairment and Early Dementia
NCT06402370 ·Status: RECRUITING
-
Big Data and Genomic Imaging for the Development of Biomarkers and Nanovector Drugs Innovative for Diagnosis and Therapy of Inflammatory Processes in Dementia
NCT05761535 ·Status: COMPLETED
-
White Matter Hyperintensities in Amnestic Mild Cognitive Impairment or Alzheimer's Disease
NCT06179680 ·Status: RECRUITING
-
Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder
NCT00029120 ·Status: COMPLETED